<DOC>
	<DOCNO>NCT02975323</DOCNO>
	<brief_summary>Portal hypertension result increase hepatic vascular resistance portal inflow . The best establish method ass portal pressure determination wedge hepatic venous pressure gradient ( HVPG ) . Ultrasound Doppler technique non-invasive assessment portal hypertension compare invasive technique measurement hepatic venous pressure gradient ( HVPG ) . Hemodynamic measurement ( BP pulse record ) do patient give tablet Carvedilol 12.5 mg single dose wait till time 20 % reduction heart rate baseline occur . Haemodynamic measurement repeat assess acute response beta-adrenoreceptor blocker agent . The change HWF record post beta-adrenoreceptor blocker administration .</brief_summary>
	<brief_title>Doppler Ultrasound Hepatic Vein Waveform Non-invasive Tool Assessment Severity Portal Hypertension</brief_title>
	<detailed_description>Ultrasound Doppler technique non-invasive assessment portal hypertension compare invasive technique measurement hepatic venous pressure gradient ( HVPG ) . The Doppler waveform hepatic vein healthy subject normally triphasic ( two negative wave one positive wave ) central venous pressure variation due cardiac cycle . The normal triphasic hepatic vein waveform transform biphasic monophasic waveform patient cirrhosis . A monophasic waveform show correlate high Child-Pugh score poor survival rate . Therefore , Hepatic vein waveform ( HVWF ) evaluation Doppler US may use supplemental tool ass severity Portal Hypertension therapeutic response portal pressure lower drug primary prophylaxis variceal bleed patient large oesophageal varix . There 's one study look topic conduct alcoholic cirrhotics . Doppler ultrasound non-invasive tool measurement portal pressure portal hypertensive patient . Hemodynamic measurement ( BP pulse record ) do patient give tablet Carvedilol 12.5 mg single dose wait till time 20 % reduction heart rate baseline occur . Haemodynamic measurement repeat assess acute response beta-adrenoreceptor blocker agent . The change HWF record post beta-adrenoreceptor blocker administration . This study validation interventional study . It open label study .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Portal</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>Patients cirrhosis large varix ( â‰¥ 5mm ) screen endoscopy Not know esophageal gastric variceal bleed Small esophageal varix ( &lt; 5 mm size ) screen endoscopy Hemodynamically unstable i.e . Blood pressure &lt; 90mmHg tachycardia &gt; 100bpm . Contraindication Betablockers ( Asthma , bradycardia , heart failure , allergy ) history Esophageal gastric variceal bleed past Hepatocellular carcinoma metastatic malignancy . Portal vein thrombosis ( PVT ) Inferior venacaval ( IVC ) thrombosis Congestive cardiac failure ( CCF ) Renal failure Hepatorenal syndrome ( Creatine &gt; 1.5 mg/dl ) Previous allergy IV contrast agent . Lactating Pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hepatic venous pressure gradient</keyword>
	<keyword>liver disease</keyword>
	<keyword>US Doppler waveform</keyword>
	<keyword>Cirrhosis</keyword>
</DOC>